COVID-19 and India: what next?

被引:1
|
作者
Behl, Ramesh [1 ]
Mishra, Manit [1 ]
机构
[1] Int Management Inst Bhubaneswar, Bhubaneswar, India
关键词
COVID-19; India; SIRD model; Basic reproduction number; Predictive modeling; Kaggle;
D O I
10.1108/IDD-08-2020-0098
中图分类号
G25 [图书馆学、图书馆事业]; G35 [情报学、情报工作];
学科分类号
1205 ; 120501 ;
摘要
Purpose - The study aims to carry out predictive modeling based on publicly available COVID-19 data for the duration April 01, 2020 to June 20, 2020 pertaining to India and five of its most infected states: Maharashtra, Tamil Nadu, Delhi, Gujarat and Rajasthan. Design/methodology/approach - The study leverages the susceptible, infected, recovered and dead (SIRD) epidemiological framework for predictive modeling. The basic reproduction number R0 is derived by an exponential growth method using RStudio package R0. The differential equations reflecting the SIRD model have been solved using Python 3.7.4 on the Jupyter Notebook platform. For visualization, Python Matplotlib 3.2.1 package is used. Findings - The study offers insights on peak-date, peak number of COVID-19 infections and end-date pertaining to India and five of its states. Practical implications - The results subtly indicate toward the amount of effort required to completely eliminate the infection. It could be leveraged by the political leadership and industry doyens for economic policy planning and execution. Originality/value - The emergence of a clear picture about COVID-19 lifecycle is impossible without integrating data science algorithms and epidemiology theoretical framework. This study amalgamates these two disciplines to undertake predictive modeling based on COVID-19 data from India and five of its states. Population-specific granular and objective assessment of key parameters such as reproduction number (RO), susceptible population (S), effective contact rate (B) and case-fatality rate (s) have been used to generate a visualization of COVID-19 lifecycle pattern for a critically affected population.
引用
收藏
页码:250 / 258
页数:9
相关论文
共 50 条
  • [31] Current pharmacological treatments for COVID-19: What's next?
    Scavone, Cristina
    Brusco, Simona
    Bertini, Michele
    Sportiello, Liberata
    Rafaniello, Concetta
    Zoccoli, Alice
    Berrino, Liberato
    Racagni, Giorgio
    Rossi, Francesco
    Capuano, Annalisa
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (21) : 4813 - 4824
  • [32] COVID-19: What is next for nursing in public health emergency?
    Zhang, Xiu-jie
    Shi, Tie-yin
    Sun, Li
    NURSE EDUCATION IN PRACTICE, 2020, 46
  • [33] COVID-19: A Crisis and a Tragedy-What's Next?
    Vicini, Andrea
    THEOLOGICAL STUDIES, 2021, 82 (01) : 116 - 137
  • [34] COVID-19 pandemic: what's next for public health?
    不详
    LANCET PUBLIC HEALTH, 2022, 7 (05): : E391 - E391
  • [35] After COVID-19: what next for older people in China?
    不详
    LANCET HEALTHY LONGEVITY, 2023, 4 (02):
  • [36] Johnny Tested Positive for COVID-19, What Is Next for the Team?
    Satin, David J.
    Simonson, Grant
    Roberts, William O.
    CURRENT SPORTS MEDICINE REPORTS, 2020, 19 (12) : 511 - 513
  • [37] The aftermath of COVID-19 in dermatology practice: What's next?
    Ng, Janice Natasha
    Cembrano, Kathryn Anne G.
    Wanitphakdeedecha, Rungsima
    Manuskiatti, Woraphong
    JOURNAL OF COSMETIC DERMATOLOGY, 2020, 19 (08) : 1826 - 1827
  • [38] COVID-19 management in India: What worked and what didn't?
    Srinivas, Voruganti
    Salwan, Prashant
    Sharma, Namrta
    Sabharwal, Meghna
    PUBLIC ADMINISTRATION AND DEVELOPMENT, 2024,
  • [39] COVID-19 in India
    Kakar, Atul
    Nundy, Samiran
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2020, 113 (06) : 232 - 233
  • [40] The COVID-19 pandemic, what can we learn for the next one?
    Ernesto Ludert, Juan
    Franco Cortes, Manuel Antonio
    UNIVERSITAS MEDICA, 2020, 61 (03):